SA
Log In
HOLX
OverviewIntelligenceChart

Analyst Sentiment

Analysts are neutral — opinion is divided on direction.

Consensus Rating
Hold
19 analysts·Moderate coverage
32%
Rating Distribution
Strong Buy
00%
Buy
632%
Hold
1368%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Price is near analyst consensus — limited near-term upside expected.

Bear Case
$76.00
-0%
Consensus
$77.75
+2%
Bull Case
$79.00
+4%
Price Range19 analysts
Low
Consensus
High
$76.00
$79.00
Current Target
Current Price
$76.01
Upside to Target
$1.74

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+4.91%
EPS+8.73%
FY2028
Rev+4.28%
EPS+7.77%
FY2029
Rev+6.65%
EPS+11.13%

Earnings Surprises

Recent Analyst Actions

Nov 21, 2025BNP Paribas
Hologic downgraded to Neutral from Outperform at BNP Paribas Exane
Target:$79.00
+6.6%from $74.12
Oct 23, 2025Mizuho Securities
Hologic downgraded to Neutral from Outperform at Mizuho
Target:$78.00
+5.5%from $73.93
Oct 22, 2025Stephens
Hologic downgraded to Equal Weight from Overweight at Stephens
Target:$76.00
+2.7%from $74.00
Oct 21, 2025Leerink Partners
Hologic price target raised to $78 from $70 at Leerink
Target:$78.00
+5.3%from $74.08
Oct 7, 2025Evercore ISI
Hologic upgraded to Outperform from In Line at Evercore ISI
Target:$78.00
+15.8%from $67.34
Jul 31, 2025Mizuho Securities
Hologic price target raised to $75 from $70 at Mizuho
Target:$75.00
+15.4%from $64.98
May 5, 2025Morgan Stanley
Hologic price target lowered to $65 from $77 at Morgan Stanley
Target:$65.00
+23.3%from $52.73
Nov 5, 2024Mizuho Securities
Hologic (HOLX) PT Lowered to $87 at Mizuho
Target:$87.00
+10.4%from $78.80
Oct 4, 2024Mizuho Securities
Hologic price target raised to $90 from $85 at Mizuho
Target:$90.00
+13.0%from $79.63
Oct 1, 2024Citigroup
Hologic downgraded to Neutral from Buy at Citi
Target:$85.00
+4.3%from $81.46
Jul 30, 2024Needham
Hologic Analysts Boost Their Forecasts After Q3 Results
Target:$90.00
+11.3%from $80.84
Jul 2, 2024Evercore ISI
Hologic price target lowered to $76 from $78 at Evercore ISI
Target:$76.00
+2.6%from $74.10
Jun 27, 2024Oppenheimer
This Vertex Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Target:$33.00
-54.8%from $73.06
May 9, 2024Argus Research
Hologic (HOLX) PT Raised to $95 at Argus
Target:$95.00
+25.2%from $75.86
Feb 2, 2023Cowen & Co.
Cowen & Co. Maintains Outperform on Hologic, Raises Price Target to $95
Target:$95.00
+13.4%from $83.77
Jan 10, 2023Wells Fargo
Wells Fargo Maintains Equal-Weight on Hologic, Raises Price Target to $80
Target:$80.00
-1.3%from $81.07
Dec 7, 2022RBC Capital
RBC Capital Initiates Coverage On Hologic with Sector Perform Rating, Announces Price Target of $75
Target:$75.00
+1.1%from $74.22
Jul 28, 2022Morgan Stanley
Morgan Stanley Maintains Equal-Weight on Hologic, Lowers Price Target to $70
Target:$70.00
-1.2%from $70.86
Jul 28, 2022Raymond James
Raymond James Maintains Outperform on Hologic, Lowers Price Target to $80
Target:$80.00
+12.2%from $71.31
May 17, 2022Leerink Partners
SVB Leerink Maintains Outperform on Hologic, Raises Price Target to $85
Target:$85.00
+10.1%from $77.22
Apr 28, 2022Citigroup
Citigroup Maintains Neutral on Hologic, Lowers Price Target to $75
Target:$75.00
+8.7%from $68.98
Apr 28, 2022Raymond James
Raymond James Maintains Outperform on Hologic, Lowers Price Target to $83
Target:$83.00
+21.3%from $68.42
Apr 28, 2022Leerink Partners
SVB Leerink Maintains Outperform on Hologic, Lowers Price Target to $82
Target:$82.00
+15.8%from $70.84
Apr 25, 2022Wells Fargo
Wells Fargo Downgrades Hologic to Equal-Weight, Lowers Price Target to $75
Target:$75.00
+1.4%from $73.93
Apr 6, 2022Evercore ISI
Hologic (HOLX) Stock: $80 Price Target From Evercore
Target:$80.00
+2.1%from $78.34

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance